Elsevier, Economic Analysis and Policy, Volume 55, 1 September 2017
This paper extends the debate about redressing persistent gender inequality in Australia by examining the relationship between labour productivity and the wage gap in all states and territories (19
Elsevier, The Lancet HIV, Volume 4, September 2017
Background Data for on-demand pre-exposure prophylaxis (PrEP) are scarce. We implemented a cohort study to assess its efficacy, safety, and effect on sexual behaviour.
Elsevier, Health Reform Policy to Practice, Oregon's Path to a Sustainable Health System: A Study in Innovation, 2017, Pages 313-332
Offers valuable lessons to develop new payment and delivery models for affordable care that aim to realign incentives and emphasize accountability for quality and efficiency.
Elsevier, Chronic Kidney Disease in Disadvantaged Populations, 2017, Pages 209-217
This book chapter advances SDGs 3 and 10 by providing a summary of recent studies of the relation of poverty to chronic kidney disease and related outcomes.
Elsevier, Chronic Kidney Disease in Disadvantaged Populations, 2017, Pages 273-289
This book chapter advances SDGs 3 and 10 by ensuring equitable access to medications, technologies and clinical care are central to service delivery for effective screening, prevention and kidney disease management.
Elsevier published Sustainability Science in a Global Landscape which analysed the sustainability science research according to six themes: Dignity, People, Prosperity, Planet, Justice, and Partnership. Key data has since been updated covering 2011 to 2015 for the top 15 countries in sustainability science output.
Elsevier, Psychiatric Clinics of North America, Volume 40, June 2017
Although sexual minority women (SMW) and transgender women have become increasingly visible in recent years and have made progress in achieving civil rights, they continue to face significant level
This book chapter advances SDG #3 and #10 by reviewing the risk factors for Alzheimer’s Disease, including normal aging, diet, sedentary lifestyle, sleep disturbances, genes [amyloid precursor protein (APP), presenilin 1 (PSEN1), PSEN2, and APOE], environmental factors, and epigenetic factors.